Europlasma Sa Stock Working Capital
ALEUP Stock | EUR 0.03 0 5.54% |
Europlasma SA fundamentals help investors to digest information that contributes to Europlasma's financial success or failures. It also enables traders to predict the movement of Europlasma Stock. The fundamental analysis module provides a way to measure Europlasma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Europlasma stock.
Europlasma |
Europlasma SA Company Working Capital Analysis
Europlasma's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Europlasma Working Capital | (9 M) |
Most of Europlasma's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Europlasma SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Competition |
In accordance with the company's disclosures, Europlasma SA has a Working Capital of (9 Million). This is 102.79% lower than that of the Commercial Services & Supplies sector and 123.93% lower than that of the Industrials industry. The working capital for all France stocks is 100.61% higher than that of the company.
Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
All Next | Launch Module |
Europlasma Fundamentals
Return On Equity | -1.1 | |||
Return On Asset | -0.19 | |||
Profit Margin | (0.27) % | |||
Operating Margin | (0.84) % | |||
Current Valuation | 6.76 M | |||
Shares Outstanding | 5.59 M | |||
Price To Earning | (0.93) X | |||
Price To Book | 0.26 X | |||
Price To Sales | 0.55 X | |||
Revenue | 9.8 M | |||
Gross Profit | 5.65 M | |||
EBITDA | (4.02 M) | |||
Net Income | (12.67 M) | |||
Cash And Equivalents | 3.92 M | |||
Cash Per Share | 0.02 X | |||
Total Debt | 2.92 M | |||
Debt To Equity | 769.60 % | |||
Current Ratio | 0.41 X | |||
Book Value Per Share | 324.39 X | |||
Cash Flow From Operations | (18.21 M) | |||
Earnings Per Share | (4,055) X | |||
Target Price | 0.3 | |||
Number Of Employees | 126 | |||
Beta | 0.72 | |||
Market Capitalization | 9.33 M | |||
Total Asset | 40.44 M | |||
Retained Earnings | (57 M) | |||
Working Capital | (9 M) | |||
Current Asset | 20 M | |||
Current Liabilities | 29 M | |||
Z Score | 0.4 | |||
Net Asset | 40.44 M |
About Europlasma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Europlasma SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Europlasma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Europlasma SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Europlasma Stock Analysis
When running Europlasma's price analysis, check to measure Europlasma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Europlasma is operating at the current time. Most of Europlasma's value examination focuses on studying past and present price action to predict the probability of Europlasma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Europlasma's price. Additionally, you may evaluate how the addition of Europlasma to your portfolios can decrease your overall portfolio volatility.